RhumbLine Advisers’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $609K | Buy |
|
|||||
|
2025
Q2 | $304K | Buy |
|
|||||
|
2025
Q1 | $2.52K | Hold |
|
|||||
|
2024
Q4 | $4.23K | Hold |
|
|||||
|
2024
Q3 | $4.18K | Hold |
|
|||||
|
2024
Q2 | $1.44K | Hold |
|
|||||
|
2024
Q1 | $1.41K | Hold |
|
|||||
|
2023
Q4 | $1.39K | Hold |
|
|||||
|
2023
Q3 | $1.15K | Hold |
|
|||||
|
2023
Q2 | $1.81K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $72K | Sell |
|
|||||
|
2018
Q4 | $67K | Buy |
|
|||||
|
2018
Q3 | $108K | Sell |
|
|||||
|
2018
Q2 | $147K | Buy |
|